Published May 29, 2024 | Version v1
Journal article Open

Pervasive nuclear envelope ruptures precede ECM signaling and disease onset without activating cGAS-STING in Lamin-cardiomyopathy mice

Description

Nuclear envelope (NE) ruptures are emerging observations in Lamin-related dilated cardiomyopathy, an adult-onset disease caused by loss-of-function mutations in Lamin A/C, a nuclear lamina component. Here, we test a prevailing hypothesis that NE ruptures trigger the pathological cGAS-STING cytosolic DNA-sensing pathway using a mouse model of Lamin cardiomyopathy. The reduction of Lamin A/C in cardio-myocyte of adult mice causes pervasive NE ruptures in cardiomyocytes, preceding inflammatory transcription, fibrosis, and fatal dilated cardiomyopathy. NE ruptures are followed by DNA damage accumulation without causing immediate cardiomyocyte death. However, cGAS-STING-dependent inflammatory signaling remains inactive. Deleting cGas or Sting does not rescue cardiomyopathy in the mouse model. The lack of cGAS-STING activation is likely due to the near absence of cGAS expression in adult cardiomyocytes at baseline. Instead, extracellular matrix (ECM) signaling is activated and predicted to initiate pro-inflammatory communication from Lamin-reduced cardiomyocytes to fibroblasts. Our work nominates ECM signaling, not cGAS-STING, as a potential inflammatory contributor in Lamin cardiomyopathy.

Data availability

High-throughput sequencing data have been deposited at Gene Expression Omnibus (http://www.ncbi.nlm.nih.gov/geo/) and are publicly available as of the date of publication. Accession numbers are listed in Key resources table.

This paper does not report original codes.

Any additional information required to reanalyze the data reported in this paper is available from Lead Contact upon request.

Files

Pervasive-nuclear-envelope-ruptures-precede-ECM-signaling-and-disease-onset.pdf

Files (40.4 MB)

Additional details

Identifiers

DOI
10.1016/j.celrep.2024.114284
Other
oai:uchicago.tind.io:12294

Funding

National Institutes of Health
R21/R33 AG054770
Cincinnati Children's Hospital Medical Center
Research Innovation and Pilot grant
National Institutes of Health
R01 HL163523
National Institutes of Health
R01 HL124836
National Institutes of Health
R01 HL126509

UChicago Information

Division(s)
Biological Sciences Division
Department(s)
Human Genetics, Pathology, Pediatrics